Market Place
Sourcing Support
Eccogene Announces Positive Phase 1 Data at AASLD 2024
15 Nov 2024 //
GLOBENEWSWIRE
Eccogene Receives $60M Milestone Payment from AstraZeneca
23 Oct 2024 //
GLOBENEWSWIRE
Eccogene Appoints Glenn Reicin as Chief Financial Officer
05 Sep 2024 //
GLOBENEWSWIRE
AZ-allied Eccogene targets early 2025 Nasdaq IPO with multiple NASH
06 May 2024 //
ENDPTS
AstraZeneca raises stakes in obesity drug race with Eccogene deal
10 Nov 2023 //
PRESS RELEASE
Eccogene nabs $25M Series B for GLP-1 and a NASH drug candidate
12 Jun 2023 //
ENDPTS
Eccogene Announces US IND Approval for THR? agonist ECC4703
01 Aug 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.